MarthaBoeriDonoghueMD

PubMed

• 8 citations
  FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement.
  Timil H Patel, Leigh Marcus, M Naomi Horiba, Martha Donoghue, Somak Chatterjee, Pallavi S Mishra-Kalyani, Robert N Schuck, Yangbing Li, Xinyuan Zhang, Jeanne Fourie Zi...> ;Clinical Cancer Research. 2023 Mar 1
• 9 citations
  FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.
  Duke, E., Stapleford, L., Drezner, N., Amatya, A., Mishra-Kalyani, P., Shen, Y., Maxfield, K., Zirkelbach, J., Bi, Y., Liu, J., Zhang, X., Wang, H., Yang, Y., Zheng, N...> ;Clinical Cancer Research. 2023 Feb 1
• 1 citations
  Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients.
  Thomas G Biel, Svetlana Petrovskaya, Francesca Mascia, Tongzhong Ju, Lola Fashoyin-Aje, Kelly M Herremans, Andrea N Riner, Patrick W Underwood, Michael H Gerber, Marth...> ;Plos One. 2023 Jan 1
• 31 citations
  FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.
  Jaleh Fallah, Michael H Brave, Chana Weinstock, Gautam U Mehta, Diana Bradford, Haley Gittleman, Erik W Bloomquist, Rosane Charlab, Salaheldin S Hamed, Claudia P Mille...> ;Clinical Cancer Research. 2022 Nov 14
• 31 citations
  FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as Single Agents for First-Line Treatment of Advanced/Metastatic PD-L1-High NSCLC.
  Oladimeji Akinboro, Erin Larkins, Lee H Pai-Scherf, Luckson N Mathieu, Yi Ren, Joyce Cheng, Mallorie H Fiero, Wentao Fu, Youwei Bi, Shyam Kalavar, Samina Jafri, Pallav...> ;Clinical Cancer Research. 2022 Jun 1
• 44 citations
  FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with Sorafenib
  May Tun Saung, Lorraine Pelosof, Sandra Casak, Martha Donoghue, Steven Lemery, Mengdie Yuan, Lisa Rodriguez, Peter Schotland, Meredith K. Chuk, Gina Davis, Kirsten B. ...> ;The Oncologist. 2021 Sep 1
• 23 citations
  FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma.
  Erica C Nakajima, Paz J. Vellanki, Erin Larkins, Somak Chatterjee, Pallavi S. Mishra-Kalyani, Youwei Bi, Hisham Qosa, Jiang Liu, Hong Zhao, Missiratch Biable, Lauren T...> ;Clinical Cancer Research. 2021 Aug 30
• 8 citations
  Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case Examples.
  Anup K. Amatya, Mallorie H. Fiero, Erik Bloomquist, Arup K. Sinha, Steven Lemery, Harpreet Singh, Amna Ibrahim, Martha Donoghue, Lola Fashoyin-Aje, R. Angelo de Claro,...> ;Clinical Cancer Research. 2021 Jun 11
• 157 citations
  FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors
  Leigh Marcus, Lola Fashoyin-Aje, Martha Donoghue, Mengdie Yuan, Lisa Rodriguez, Pamela S. Gallagher, Reena Philip, Marc R. Theoret, Julia A. Beaver, Richard Pazdur, St...> ;Clinical Cancer Research. 2021 Jun 3
• 6 citations
  Benefit-Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Flu...
  Lorraine Pelosof, May Tun Saung, Martha Donoghue, Sandra Casak, Sirisha Mushti, Joyce Cheng, Xiling Jiang, Jiang Liu, Hong Zhao, Maryam Khazraee, Kirsten B. Goldberg, ...> ;The Oncologist. 2021 Apr 1
• 3 citations
  FDA Oncology Center of Excellence Project Renewal: Engaging the Oncology Community to Update Product Labeling for Older Oncology Drugs.
  Paul G. Kluetz, Patricia Keegan, George D. Demetri, Katherine Anne Thornton, Joohee Sul, Janice Kim, Harvey Katzen, Laurie B. Burke, R. Donald Harvey, Elleni Alebachew...> ;Clinical Cancer Research. 2021 Feb 15
• 25 citations
  FDA Supplemental Approval Summary: Lenvatinib for the Treatment of Unresectable Hepatocellular Carcinoma.
  Abhilasha Nair, Kelie Reece, Martha Donoghue, Weishi Vivian Yuan, Lisa Rodriguez, Patricia Keegan, Richard Pazdur> ;The Oncologist. 2021 Mar 1
• 142 citations
  FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD‐L1
  Lola Fashoyin-Aje, Martha Donoghue, Huanyu Chen, Kun He, Janaki Veeraraghavan, Kirsten B. Goldberg, Patricia Keegan, Amy E. McKee, Richard Pazdur> ;The Oncologist. 2019 Jan 1
• 45 citations
  FDA Benefit‐Risk Assessment of Osimertinib for the Treatment of Metastatic Non‐Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation
  Lauretta Odogwu, Luckson Mathieu, Kirsten B. Goldberg, Gideon M. Blumenthal, Erin Larkins, Mallorie H. Fiero, Lisa Rodriguez, Karen Bijwaard, Eunice Y. Lee, Reena Phil...> ;The Oncologist. 2018 Mar 1
• Join now to see all